Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 5.25% is 54% below its 5-year average of 11.34%, near the low end of its 5-year range (3.83%–16.60%).
12.21% below its 12-month average of 5.98%.
Annual fiscal-year return on equity; no daily interpolation.
RETURN ON EQUITY (ROE)
5.25%
RETURN ON EQUITY (ROE) AVG TTM
5.98%
RETURN ON EQUITY (ROE) AVG 3Y
10.62%
RETURN ON EQUITY (ROE) AVG 5Y
11.34%
RETURN ON EQUITY (ROE) AVG 10Y
10.97%
RETURN ON EQUITY (ROE) AVG 15Y
12.97%
RETURN ON EQUITY (ROE) AVG 20Y
15.12%
CURRENT VS TTM AVG
-12.21%
CURRENT VS 3Y AVG
-50.54%
CURRENT VS 5Y AVG
-53.70%
CURRENT VS 10Y AVG
-52.13%
CURRENT VS 15Y AVG
-59.53%
CURRENT VS 20Y AVG
-65.28%
SECTOR MEDIAN · HEALTHCARE
13.38%
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
-60.76%
vs the sector median at left
Bio-Techne Corporation
Market Cap
$11.30B
Return on Equity (ROE)
5.25%
TTM Avg
5.98%
3Y Avg
10.62%
5Y Avg
11.34%
Market Cap
$11.45B
Return on Equity (ROE)
-114.70%
TTM Avg
329.18%
3Y Avg
200.63%
5Y Avg
164.66%
Market Cap
$10.21B
Return on Equity (ROE)
20.31%
TTM Avg
18.80%
3Y Avg
15.17%
5Y Avg
15.31%
Market Cap
$12.39B
Return on Equity (ROE)
9771.59%
TTM Avg
10.54%
3Y Avg
10.84%
5Y Avg
19.93%
Market Cap
$10.16B
Return on Equity (ROE)
12.09%
TTM Avg
11.88%
3Y Avg
12.69%
5Y Avg
13.50%
Market Cap
$10.15B
Return on Equity (ROE)
-0.17%
TTM Avg
18.91%
3Y Avg
22.60%
5Y Avg
24.60%
Market Cap
$10.02B
Return on Equity (ROE)
26.39%
TTM Avg
25.41%
3Y Avg
19.99%
5Y Avg
14.02%
Market Cap
$9.76B
Return on Equity (ROE)
-57.18%
TTM Avg
-651.33%
3Y Avg
-315.37%
5Y Avg
-198.08%
Market Cap
$12.91B
Return on Equity (ROE)
3.29%
TTM Avg
3.59%
3Y Avg
3.35%
5Y Avg
7.68%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Techne Corporation (TECH) | $11.30B | 5.25% | 5.98% | 10.62% | 11.34% |
| DaVita Inc. (DVA)vs › | $11.45B | -114.70% | 329.18% | 200.63% | 164.66% |
| Universal Health Services, Inc. (UHS)vs › | $10.21B | 20.31% | 18.80% | 15.17% | 15.31% |
| Align Technology, Inc. (ALGN)vs › | $12.39B | 9771.59% | 10.54% | 10.84% | 19.93% |
| Henry Schein, Inc. (HSIC)vs › | $10.16B | 12.09% | 11.88% | 12.69% | 13.50% |
| Molina Healthcare, Inc. (MOH)vs › | $10.15B | -0.17% | 18.91% | 22.60% | 24.60% |
| Insulet Corp. (PODD)vs › | $10.02B | 26.39% | 25.41% | 19.99% | 14.02% |
| Tempus AI, Inc. (TEM)vs › | $9.76B | -57.18% | -651.33% | -315.37% | -198.08% |
| Revvity, Inc. (RVTY)vs › | $12.91B | 3.29% | 3.59% | 3.35% | 7.68% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.59B | 3.10% | -8.94% | -15.72% | 1.14% |
ROE
5.3%
ROA
4.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-06-30 | 3.83% |
| 2024-06-30 | 8.13% |
| 2023-06-30 | 14.51% |
| 2022-06-30 | 15.99% |
| 2021-06-30 | 8.98% |
| 2020-06-30 | 16.60% |
| 2019-06-30 | 8.24% |
| 2018-06-30 | 11.62% |
| 2017-06-30 | 8.13% |
| 2016-06-30 | 11.88% |
| 2015-06-30 | 12.72% |
| 2014-06-30 | 13.95% |
| 2013-06-30 | 15.26% |
| 2012-06-30 | 16.66% |
| 2011-06-30 | 19.16% |
| 2010-06-30 | 21.88% |
| 2009-06-30 | 23.06% |
| 2008-06-30 | 21.26% |
| 2007-06-30 | 19.45% |
| 2006-06-30 | 21.55% |
| 2005-06-30 | 24.69% |
| 2004-06-30 | 17.80% |
| 2003-06-30 | 19.19% |
| 2002-06-30 | 13.14% |
| 2001-06-30 | 19.16% |
| 2000-06-30 | 18.83% |
| 1999-06-30 | 17.25% |
| 1998-06-30 | 23.82% |
| 1997-06-30 | 22.66% |
| 1996-06-30 | 22.11% |
